Children are enrolled for a transmission assessment survey at Trou du Nord, in the northern part of Haiti, in 2015. (Photo by Dr. Alaine Knipes)

Overview

IMA World Health began its work in Haiti in 1998, partnering with the Haitian Ministry of Health and others to open a clinic to treat lymphedema, one of the debilitating symptoms of lymphatic filariasis, or LF. Since then, IMA has supported health in Haiti in a variety of ways.

IMA began distributing preventive treatment for LF in Haiti through mass drug administration in 2007; and then in 2011, IMA became the lead implementing partner in Haiti for the ENVISION project to combat LF and soil transmitted helminths. Our work expanded in 2015 when, in partnership with Episcopal Relief & Development, IMA launched the Healthy Schools, Successful Children project to address water, sanitation and hygiene issues in Haitian schools. IMA also developed and maintains a public-private partnership with TOMS, an American footwear company, to provide children in Haiti with hundreds of thousands of pairs of new shoes, which are the first line of defense against soil-transmitted helminthes or STH infection.

Our Projects

Haiti ENVISION Project

USAID through RTI International | 2012-2019

As the lead implementing partner for ENVISION in Haiti, IMA has worked alongside the Haiti Neglected Tropical Disease Control Program, a joint effort between the Ministry of Health and Population (MSPP), the Ministry of Education and other partners. With funding from USAID and leadership from RTI International, IMA helps the government to provide mass drug administration (MDA) through community posts and schools across Haiti’s 10 departments to treat LF and STH.  

IMA has trained approximately 34,000 community leaders, promoters and distributors to educate the population about LF and STH, persuade the highest number of households possible to participate in MDA and conduct MDA. In Haiti, IMA led the scale-up of nationwide treatment and treated nearly 6 million people annually for LF and STH. Following guidance from the World Health Organization (WHO), IMA and its partners also conduct transmission assessment surveys (TAS) in communes which have had at least five consecutive MDAs at high coverage and a prevalence of MF <1% or Ag <2% in sentinel and spot-check sites. Of the 140 communes in Haiti, 118 communes are now under surveillance with 22 communes still undergoing MDA.

IDA Triple Drug Therapy in Haiti

2017-2018

With funding by the Bill and Melinda Gates Foundation/University of Washington, Haiti was selected as one of five countries to participate in a high-profile clinical safety and efficacy trial and acceptability study. The study—which was led by the Haiti MSPP, U.S. Centers for Disease Control and Prevention (CDC), RTI and the University of Florida with IMA as the implementing partner—has been instrumental in facilitating progress toward the global LF elimination effort and shaping WHO’s LF treatment guidance.

Healthy Schools, Successful Children (Sante nan lekol, se sikse timoun yo)

$1.96 million | Episcopal Relief & Development | 2015-2018

According to a Ministry of Education report, more than 74 percent of Haiti’s schools lack a water installation, 84 percent lack treated drinking water and more than 40 percent lack functional toilets or latrines. In 2015, IMA partnered with member agency Episcopal Relief & Development to improve students’ health, school participation and educational success through water, sanitation and hygiene interventions in 60 public and Episcopalian schools in the Southeast, South and Grand’Anse departments. The project aims to provide or build latrines, reservoirs, water filters, and handwashing stations in schools as well as establish frameworks that enable schools and communities to sustain progress and maintain the infrastructure beyond the project’s lifespan.

Partnership with TOMS

TOMS | 2010-present

Shoes are one of the first levels of defense when it comes to good health—and they are a great complement to the ENVISION program IMA implements in Haiti. In 2010, IMA and TOMS partnered to add shoe distribution to its work to prevent and treat hookworm and other neglected tropical diseases. Using the same network of volunteers who distribute drugs at MDAs, IMA has efficiently worked with TOMS to provide new shoes to school children to help keep them healthy and able to attend school. In addition to preventing cuts and injuries that can become infected, shoes help prevent the spread of hookworm and other soil-transmitted diseases that can enter through the feet. Shoes are also required for school enrollment.